Skip to main content
Premium Trial:

Request an Annual Quote

Health Discovery, Teranode, Sun Microsystems


Health Discovery Acquires Patents for SVMs in Medicine

Health Discovery Corporation said last week that it has acquired the rights to a portfolio of 71 patents and pending patent applications on support vector machines and other machine-learning tools with applications in diagnostics and drug discovery

Teranode Secures $2.6M Series A Round

Teranode said last week that it as closed a $2.6M Series A round of financing led by Ignition Partners. Teranode’s existing investors — the Washington Research Foundation and Prima Electronics — also participated in the funding round.

The Seattle-based firm markets the VLX Design Suite, a biological modeling and experimental design platform. The company’s customers include Pfizer, AstraZeneca, Fred Hutchinson Cancer Research Center, and St. Jude’s Hospital.

Teranode said that its previous funding includes a $1.8 million NIH grant, “undiluted funds” from the NSF and Intel Research, seed funding from the Washington Research foundation, and private investors.

The cash will help expand its development and support teams and invest in marketing and partnerships.

Sun Seeks Papers for Comp Bio Conference

Sun Microsystems has issued a call for papers for a conference it is organizing at its computational biology Center of Excellence in Research Triangle Park, NC, Oct. 28-29.

The conference, “Bridging Knowledge Gaps in Computational Biology,” will address several “bridges” necessary for advancing computational biology, according to the organizers, including data technologies for handling distributed data, ontologies and pathway representations, and commercial applications for computational biology research.

The call for papers expires Sept. 10. Abstracts can be sent to [email protected].

Filed under

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.